Neurogene Inc. (NGNE) — Institutional Holders, Q2 2026 (page 2)

112 institutional investment managers reported a NGNE position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $544.4M. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 101 to 112. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

NGNE 13F holders ranked 101–112 of 112

Institutional investors reporting a position in Neurogene Inc. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Parallel Advisors#101 · 35 sh$1.1K-63.5%
Optiver Holding B.V.#102 · 32 sh$1.0K-52.2%
EverSource Wealth Advisors#103 · 27 sh$849.00-79.2%
Essential Partners#104 · 20 sh$629.000.0%
Investors Portfolio Services#105 · 15 sh$472.000.0%
Fortitude Family Office#106 · 8 sh$252.00New
NATIONAL BANK OF CANADA#107 · 8 sh$249.000.0%
Hughes Financial Services#108 · 2 sh$63.00New
Clearstead Advisors#109 · 1 sh$32.00New
IFP Advisors#110 · 1 sh$31.000.0%
Larson Financial Group#111 · 1 sh$31.000.0%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM#112 · 156 sh—-74.2%

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.